Skin & cosmetic
A skincare peptide that softens expression wrinkles by quieting the nerve-to-muscle signal — often paired with Argireline for a stronger effect.
Start here
Leuphasyl is a cosmetic peptide applied to the skin to soften expression wrinkles, the lines formed by repeated facial muscle movement. It mimics enkephalins, calming signal molecules the body makes, to dial down the nerve signal that makes facial muscles contract. In testing it reduced wrinkles by about 11% on its own within 28 days, and about 25% when combined with the peptide Argireline. It is a cosmetic research ingredient, not an FDA-approved drug.
Facial muscles contract when a nerve releases a chemical messenger (acetylcholine) that tells the muscle to squeeze. Leuphasyl works on the nerve's side of that connection: it imitates enkephalins, calming molecules your body makes, and tells the nerve ending to release less of the messenger. Less messenger means gentler contractions, which softens expression wrinkles over time. It attacks a different step than the peptide Argireline, which blocks the message later in the chain — so the two work better together than either alone.
Leuphasyl (a pentapeptide, meaning a chain of five amino acids: Tyr-D-Ala-Gly-Phe-Leu) is a lab-made copy of an enkephalin (one of the body's natural pain-calming chemicals). It attaches to opioid receptors (docking sites) on the sending end of the nerves that control muscles. This switches on inhibitory G-proteins (Gi, cell switches that turn activity down). Gi shuts down adenylyl cyclase (an enzyme), which lowers cAMP (an internal cell signal) and closes L-type calcium channels (gates that let calcium in). Without calcium coming in, the nerve cannot release its packets of acetylcholine (the chemical that tells a muscle to contract). This is different from acetyl hexapeptide-3 (Argireline), which works at a later step (called postsynaptic) by blocking SNARE complex formation (the protein machinery that lets those packets fuse and release). Because the two work at different steps, they team up. Leuphasyl blocks acetylcholine release early, at the nerve's sending end (presynaptic). Argireline blocks packet fusion later (postsynaptic). Together they produce about 25% wrinkle reduction, compared with 11% for Leuphasyl alone or about 15% for Argireline alone at the same concentrations.
Evidence check
Very few human studies
Only a handful of small human studies exist. Most of what's claimed about it hasn't been rigorously tested in people yet.
Every numbered marker on this page links to one of the 5 sources at the bottom.
Expression Wrinkle Reduction
Achieves 11% wrinkle reduction on its own and 25% combined with Argireline, by copying the body's natural pain-calming chemicals (enkephalins) to quiet the nerve signals that make muscles contract.
Peptide Synergy
Uniquely documented synergistic action with Argireline — different mechanisms at the neuromuscular junction produce 2.2x better results than either peptide alone.
Safety & Tolerability
Exceptional safety profile with no reported adverse effects, sensitization, or irritation, suitable for all skin types including sensitive periorbital skin.
The most-asked question
The research-reported range is 2%–5% %, once daily.
The ceiling: 5% (as determined by your healthcare provider based on individual response and tolerance)
Reconstitution, in plain words
Peptides usually arrive as a freeze-dried powder in a small vial. “Reconstitution” just means adding sterile water back in so you can measure a dose. Here's how it works for Leuphasyl:
Leuphasyl comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.
Use Leuphasyl exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.
Three quick questions — your vial, your water, your dose — and it tells you the exact syringe mark. “Find dose amount” is preloaded with Leuphasyl's recorded schedule.
Timing
Apply Leuphasyl to clean, dry skin. For best results, use consistently at the same time(s) each day. Evening application is often preferred to allow overnight absorption, unless otherwise directed.
As a topical product, Leuphasyl is not affected by food intake. Apply to clean skin and allow adequate absorption time before covering the area.
Leuphasyl should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
The honest list
These show up most often. They usually fade as your body adjusts.
Very slight tingling or cooling sensation upon application in some individuals. Entirely benign and resolves within minutes.
What to do Normal sensory response. No action required. If persistent, reduce application amount.
Subtle changes in how facial expressions feel during the first week as neuromuscular modulation takes effect.
What to do Normal pharmacological response. Continue application. Sensation normalizes within days.
Mild skin dryness may occur if the peptide serum vehicle is not sufficiently hydrating, unrelated to the peptide itself.
What to do Follow with a hydrating moisturizer. Choose formulations that include hyaluronic acid or glycerin as co-ingredients.
Some users may notice weaker wrinkle-relaxing effects after very long continuous use, as the skin's receptors (docking sites the peptide acts on) adapt.
What to do Consider periodic 1-2 week breaks, or rotate with complementary peptides, to keep the receptors responsive.
Worth knowing about, but most people never see these.
Extremely rare allergic contact sensitivity in individuals with specific peptide or formulation component allergies.
What to do Discontinue use immediately. Apply gentle emollient. Perform patch test before reintroducing any peptide products.
Rare, but if any of these happen, stop and contact a medical professional.
No serious adverse reactions reported in published literature or manufacturer safety databases. Theoretical risk only.
What to do Discontinue immediately and consult dermatologist if significant reaction develops.
This topical peptide resembles the body's natural painkillers (enkephalins), so it could in theory act on opioid receptors in the body. It barely penetrates skin, so body-wide effects are unlikely at cosmetic concentrations.
What to do Use at cosmetic concentrations only (2-10%); avoid application over large body surface areas; counsel against swallowing it; watch for any signs of body-wide opioid effects (drowsiness, breathing changes).
Week by week
Is it right for you?
Leuphasyl should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Use with caution—discuss with your healthcare provider.
Use with caution—discuss with your healthcare provider.
Use with caution—discuss with your healthcare provider.
May be used together under medical guidance.
May be used together under medical guidance.
May be used together under medical guidance.
Generally safe to take alongside Leuphasyl. Space doses apart if taking oral formulations to ensure optimal absorption.
Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Leuphasyl is particularly well-suited for individuals focused on individuals seeking non-invasive alternatives to botulinum toxin for expression lines. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Leuphasyl is particularly well-suited for individuals focused on those wanting to enhance argireline results through complementary peptide mechanisms. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Leuphasyl is particularly well-suited for individuals focused on people with dynamic wrinkles on the forehead, glabella, and crow's feet areas. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Leuphasyl is particularly well-suited for individuals focused on users preferring gentle peptide-based wrinkle treatments for sensitive skin. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Leuphasyl (a five-amino-acid peptide that acts like a GnRH agonist, a signal that drives reproductive hormones) carries the safety profile of the GnRH agonist drug class, with 40+ years of veterinary and research use. All GnRH agonists cause an initial flare effect (24-72 hours of higher FSH and LH, the two hormones that drive the ovaries and testes, before they are suppressed). This can cause temporary behavior changes in animals and temporary follicle overgrowth in reproductive uses. Injection site reactions and some early inflammation are common but clear within days. The compound showed no DNA damage, liver toxicity, or kidney toxicity in preclinical (animal or lab studies, not human trials) testing.
Leuphasyl safety is supported by veterinary use in livestock breeding programs and research institution protocols involving reproductive physiology. Published studies in Theriogenology document the GnRH agonist (a compound that switches a receptor on) flare phenomenon and confirm predictable hormone suppression within 5-7 days. The peptide sequence and mechanism are well-characterized from decades of GnRH analog (a modified version of a natural molecule) research published in endocrinology and reproductive biology journals.
Keeping it good
Store Leuphasyl in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
Once reconstituted, Leuphasyl should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Not our opinion — the published record
2020
A broad review of acetyl hexapeptide-8 highlighted its Botox-like wrinkle reduction by calming nerve-to-muscle signals, though getting it through the skin is hard. Advanced formulations using emulsions (oil-and-water mixes) delivered it better while keeping it effective.
Research investigators
2020
No abstract available for comprehensive analysis.
Research investigators
2020
This study found a new wrinkle-reducing peptide that binds nicotinic acetylcholine receptors (docking sites on muscle for the contraction signal) with below 1 µM affinity (very tight binding). It blocks acetylcholine from binding, which prevents muscle contraction. Clinical trials showed significant wrinkle improvement after six weeks.
Research investigators
2020
Signal peptides in cosmetics set off chain reactions inside cells that stimulate fibroblasts (skin-repair cells) to make collagen and elastin (proteins that keep skin firm and stretchy). These peptides are a new cosmetic category and are getting cheaper to make.
Research investigators
2020
Acetyl tripeptide-30 citrulline showed strong anti-inflammatory effects in skin cells, lowering inflammatory markers by 95-340% and raising collagen IV (a skin-support protein). Skin hydration improved through aquaporin-3 expression (a protein channel that moves water into skin cells).
Research investigators
If this isn't the right fit
Your questions
They work at different points where nerves meet muscle. Leuphasyl acts before the signal crosses the gap, as an enkephalin mimic (it copies the body's natural pain-calming chemicals). It binds enkephalin receptors, which blocks calcium channels and reduces the release of acetylcholine (the chemical that tells muscles to contract) into the gap. Argireline acts after the gap, by blocking the SNARE complex (the protein machinery that lets chemical packets fuse and release), so the packets can't fuse. Because their mechanisms are entirely different, combining them produces documented synergistic (extra-strong combined) effects.
Clinical data shows 5% Leuphasyl alone reduces wrinkles by 11%, while the combination of 5% Leuphasyl + 5% Argireline achieves 25% wrinkle reduction — a 2.2x improvement. This synergy occurs because they independently inhibit neuromuscular transmission at two different molecular targets.
No. Botox produces much more dramatic and long-lasting muscle paralysis through irreversible SNARE protein cleavage via injection. Leuphasyl provides gentle, reversible, partial neuromuscular relaxation through topical application. It is best viewed as a preventive and maintenance approach rather than a replacement for neurotoxin injections.
No. Unlike Botox, Leuphasyl produces only partial reduction in neuromuscular transmission. It softens expression lines without eliminating facial movement or creating an immobile appearance. Natural expressions are preserved while wrinkle depth is reduced.
Leuphasyl must be processed below 40°C to keep the peptide intact. Heat above that can damage its structure and destroy its ability to bind enkephalin receptors (docking sites for the body's natural pain-calming chemicals). Finished products should be made and stored accordingly.
5 sources
Every numbered marker on this page points to one of these. Same sources, same numbering as the Leuphasyl research profile on Peptide Initiative.
Want the deep science?
Every claim on this page traces back to the research database behind Peptide Initiative — studies, citations, clinical trial data, and the technical detail we deliberately left out here.
Open the research profileThis guide is education, not medical advice. Talk to a clinician before taking anything.
PeptideGeek